Inhibikase Therapeutics Price Chart
Inhibikase Therapeutics Volume Chart
Inhibikase Therapeutics Market Segments
After Hours
*No Trades in Segment
Regular Trading Hours
+0.03(+1.60%)
| Open | $1.87 |
|---|---|
| Close | $1.90 |
| Low | $1.83 |
| Low Change | -0.04 (-2.14%) |
| High | $1.91 |
| High Change | +0.04 (+2.14%) |
| Range | $0.08 |
| Volume | 796.543K |
| Dollar Volume | $1.51M |
Premarket
+0.03(+1.58%)
| Open | $1.90 |
|---|---|
| Close | $1.93 |
| Low | $1.90 |
| Low Change | 0.00 (0.00%) |
| High | $1.93 |
| High Change | +0.03 (+1.58%) |
| Range | $0.03 |
| Volume | 3K |
| Dollar Volume | $5.79K |
After Hours Yesterday
+0.00(+0.00%)
| Open | $1.93 |
|---|---|
| Close | $1.93 |
| Low | $1.93 |
| Low Change | 0.00 (0.00%) |
| High | $1.93 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 1.2K |
| Dollar Volume | $2.32K |
Regular Trading Hours Yesterday
+0.03(+1.61%)
| Open | $1.86 |
|---|---|
| Close | $1.89 |
| Low | $1.86 |
| Low Change | 0.00 (0.00%) |
| High | $1.94 |
| High Change | +0.08 (+4.30%) |
| Range | $0.08 |
| Volume | 354.339K |
| Dollar Volume | $669.70K |
Premarket Yesterday
+0.00(+0.00%)
| Open | $1.85 |
|---|---|
| Close | $1.85 |
| Low | $1.85 |
| Low Change | 0.00 (0.00%) |
| High | $1.85 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 800 |
| Dollar Volume | $1.48K |
Inhibikase Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $1.88 |
|---|---|
| 10 Day Moving Average (SMA10) | $1.84 |
| 20 Day Moving Average (SMA20) | $1.79 |
| 50 Day Moving Average (SMA50) | $1.83 |
| 100 Day Moving Average (SMA100) | $1.76 |
| 200 Day Moving Average (SMA200) | $1.70 |
Inhibikase Therapeutics Statistics
| Average Volume (30 Days) | 1.45M |
|---|---|
| P/E Ratio (Current) | -5.08 |
| EPS (Current) | -$0.37 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$27.80M |
| Cash Ratio | 16.77 |
| Current Ratio | 21.70 |
| Quick Ratio | 21.70 |
| Debt to Equity | 0.00 |
| Enterprise Value | $109.00M |
| EV to EBITDA | -2.10 |
| EV to Sales | — |
| Price to Book | 1.44 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | -0.27% |
| Return on Equity | -0.28% |
Inhibikase Therapeutics Stock Splits
There has been 1 stock split for Inhibikase Therapeutics (IKT). The reverse stock split occured on June 30, 2023 and reduced the outstanding shares at a ratio of 6:1.
| Date | Type | Ratio |
|---|---|---|
| Jun 30, 2023 | Reverse | 6:1 |
Inhibikase Therapeutics Dividends
There have been no dividends for Inhibikase Therapeutics (IKT).